Clinical Drug Experience Knowledgebase

Polycythemia Vera

Primary Myelofibrosis

Acquired Immunodeficiency Syndrome (Phase 2)

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Anemia (Phase 2)

Anemia, Hemolytic (Phase 2)

Anemia, Hemolytic, Autoimmune (Phase 2)

Anemia, Sickle Cell (Phase 1)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Biliary Tract Neoplasms (Phase 2)

Blast Crisis (Phase 2)

Breast Carcinoma In Situ (Phase 2)

Breast Diseases (Phase 2)

Breast Neoplasms (Phase 2)

Bronchiolitis (Phase 2)

Bronchiolitis Obliterans (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Basal Cell (Phase 1)

Carcinoma, Ductal (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma in Situ (Phase 2)

Carcinoma, Intraductal, Noninfiltrating (Phase 2)

Carcinoma, Lobular (Phase 2)

Carcinoma, Merkel Cell (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Small Cell (Phase 1)

Carcinoma, Squamous Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 3)

Cholangiocarcinoma (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Colorectal Neoplasms (Phase 2)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Nephropathies (Phase 2)

Eczema (Phase 3)

Endometrial Neoplasms (Phase 2)

Eosinophilia (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 1)

Fallopian Tube Neoplasms (Phase 1)

Fatigue (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Graft vs Host Disease (Phase 3)

Head and Neck Neoplasms (Phase 2)

Hemolysis (Phase 2)

Hepatomegaly (Phase 2)

Hidradenitis (Phase 2)

Hidradenitis Suppurativa (Phase 2)

Histiocytoma, Malignant Fibrous (Phase 1)

HIV Infections (Phase 2)

Hodgkin Disease (Phase 2)

Hypereosinophilic Syndrome (Phase 2)

Hyperplasia (Phase 2)

Infections (Phase 2)

Inflammatory Breast Neoplasms (Phase 2)

Insulin Resistance (Phase 1)

Kidney Diseases (Phase 2)

Leiomyosarcoma (Phase 1)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Leukemia, Myelomonocytic, Acute (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Liposarcoma (Phase 2)

Liposarcoma, Myxoid (Phase 1)

Lung Neoplasms (Phase 3)

Lupus Erythematosus, Systemic (Phase 3)

Lymphohistiocytosis, Hemophagocytic (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 3)

Lymphoma, Follicular (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 3)

Mesothelioma (Phase 1)

Microsatellite Instability (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 3)

Nasopharyngeal Carcinoma (Phase 2)

Nasopharyngeal Neoplasms (Phase 1)

Neoplasm Metastasis (Phase 2)

Neoplasm, Residual (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Pemphigus (Phase 2)

Penile Neoplasms (Phase 2)

Peritoneal Neoplasms (Phase 2)

Philadelphia Chromosome (Phase 2)

Polycythemia (Phase 3)

Polycythemia Vera (Phase 3)

Precancerous Conditions (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 3)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Rectal Neoplasms (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 1)

Sarcoma, Synovial (Phase 1)

Sjogren's Syndrome (Phase 2)

Skin Diseases (Phase 2)

Skin Diseases, Papulosquamous (Phase 2)

Skin Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 1)

Splenomegaly (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 2)

Thrombocythemia, Essential (Phase 3)

Thrombocytosis (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Ulcer (Phase 2)

Undifferentiated Connective Tissue Diseases (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uveal Neoplasms (Phase 2)

Vitiligo (Phase 3)